prescription drugs

It costs $5 a month and includes generic medications for more than 80 common health conditions.

The Biden administration will use data from EMS first responders to track overdoses. The focus will be on improving response to a public health crisis that kills more than 100,000 Americans annually.

The cash represents an unprecedented opportunity to derail the opioid epidemic. But with countless groups advocating for a share of the pie, the impact could depend heavily on geography and politics.

The retail giant becomes the latest major player in the drug industry to announce a plan to settle lawsuits filed by state and local governments over the toll of opioids sold at its pharmacies.

The FDA announced a shortage of Adderall and its generics last month. Oklahomans have been jumping through hoops to get their medication.

It could amount to the last round of huge settlements after years of litigation over the industry's role in an overdose crisis linked to more than 500,000 deaths in the U.S. over the past two decades.

The Inflation Reduction Act gives Medicare historic new powers to limit prescription drug prices. But the pharmaceutical industry is already lobbying to dull their impact.

On Friday, the House sent to President Biden's desk what Democrats call a historic piece of legislation, but it's still a much smaller version of what they — and Biden — originally called for.

The Arizona senator said she will move forward with the Inflation Reduction Act after Democrats reached an agreement to remove a carried interest tax provision.

Two Washington Post journalists say pharmaceutical companies collaborated with each other — and with lawyers and lobbyists — to create laws to protect the industry. Their new book is American Cartel.